市場調査レポート

商品コード

デジタルセラピューティクス（DTx）の市場規模、シェア、収益分析、オファリング別、収益モデル別、用途別、流通チャネル別、地域別 - 産業予測、2024年～2031年

Digital Therapeutics Market Size, Share, Growth Analysis, By Offering, By revenue model, By application, By distribution channel, By Region - Industry Forecast 2024-2031

出版日: 2024年09月10日
発行: SkyQuest
ページ情報: 英文 274 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

デジタルセラピューティクス（DTx）の世界市場規模は2022年に34億4,000万米ドルとなり、予測期間（2024-2031年）のCAGRは16.61%で、2023年の40億1,000万米ドルから2031年には137億2,000万米ドルに成長する見通しです。

世界のデジタルセラピューティクス（DTx）市場は、ヘルスケアの技術進歩や慢性疾患の蔓延の増加により、急速に拡大しています。デジタルセラピューティクス（DTx）は、エビデンスに基づき臨床的に検証された治療を通じて病状を治療または管理するために設計されたソフトウェア主導の介入です。これらのソリューションは、糖尿病、心血管疾患、呼吸器疾患、メンタルヘルス問題など、様々な健康状態の管理に使用されています。従来の薬物治療に代わる、あるいは補完する治療法であり、多くの場合、行動修正、遠隔モニタリング、患者教育に重点が置かれています。市場成長の主な要因としては、遠隔ヘルスケアサービスに対する需要の高まり、モバイルヘルス（mヘルス）技術の採用拡大、価値ベースのヘルスケアモデルの受け入れ拡大などが挙げられます。デジタルセラピューティクス（DTx）治療プロトコルへの患者のアドヒアランスを向上させ、リアルタイムのデータインサイトを提供し、個人がより効果的に健康を管理できるようにします。政府やヘルスケアプロバイダーは、医療費の削減と患者の転帰の改善におけるDTxの可能性をますます認識しつつあります。

市場概要
治療・ケア関連用途
- 糖尿病
- 中枢神経系（CNS）障害
- 精神疾患
- その他の中枢神経系疾患
- 禁煙
- 慢性呼吸器疾患
- 筋骨格障害
- 心血管疾患
- 服薬遵守
- 胃腸障害
- リハビリテーションと患者ケア
- 物質使用障害と依存症管理
- その他の治療/ケア関連用途
予防的用途
- 前糖尿病
- 肥満
- 栄養
- ライフスタイル管理
- その他の予防的用途

デジタルセラピューティクス（DTx）市場：収益モデル別

市場概要
サブスクリプションベースモデル
1回限りの購入/年間ライセンシングモデル
成果/価値ベースのモデル

デジタルセラピューティクス（DTx）市場：販売チャネル別

市場概要
B2B販売チャネル
- 支払者
- 雇用主
- 製薬会社
- プロバイダー
- その他の購入者
B2C販売チャネル
- 介護者
- 患者

デジタルセラピューティクス（DTx）市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

ANSYS（US）
Dassault Systemes（SIMULIA）（France）
PTC（Creo）（US）
Siemens Digital Industries Software（Simcenter）（Germany）
Autodesk（Simulation）（US）
OpenFOAM（Open-source）（N/A）
STAR-CCM+（US/Germany）
COMSOL Multiphysics（Sweden）
CD-adapco（STAR-CD, STAR-CCM+）（US/Germany）
Altair（HyperWorks）（US）
ESI Group（France）
MSC Software（MSC Adams, MSC Marc）（US）
MathWorks（MATLAB/Simulink）（US）
Flow3D（US）
Fluent（US）
CONVECTION（US）
Cadence Design Systems（US）
Synopsys（US）
Numerica（US）
Pointwise（US）

Product Code: SQMIG35G2136

Global Digital Therapeutics Market size was valued at USD 3.44 billion in 2022 and is poised to grow from USD 4.01 billion in 2023 to USD 13.72 billion by 2031, at a CAGR of 16.61 % during the forecast period (2024-2031).

Global digital therapeutics market is expanding rapidly, driven by technological advancements in healthcare and the increasing prevalence of chronic diseases. Digital therapeutics (DTx) are software-driven interventions designed to treat or manage medical conditions through evidence-based, clinically validated therapies. These solutions are used to manage a variety of health conditions, including diabetes, cardiovascular diseases, respiratory disorders, and mental health issues. They offer an alternative or complement to traditional drug treatments, often focusing on behavior modification, remote monitoring, and patient education. Key factors contributing to market growth include the rising demand for remote healthcare services, the increasing adoption of mobile health (mHealth) technologies, and the growing acceptance of value-based healthcare models. Digital therapeutics improve patient adherence to treatment protocols, provide real-time data insights, and empower individuals to manage their health more effectively. Governments and healthcare providers are increasingly recognizing the potential of DTx in reducing healthcare costs and improving patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Therapeutics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Therapeutics Market Segmental Analysis

Global digital therapeutics market is segmented on the basis of offering, revenue model, application, sales channel, and region. By offering, market is segmented into software/platforms, programs, virtual reality/games. By revenue model, market is segmented into subscription-based model, one-time purchase/annual licensing model, and outcome /value-based model. By application, market is segmented into treatment/care-related applications, and preventive applications. By distribution channel, market is segmented into B2B sales channel, and B2C sales channel. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Digital Therapeutics Market

The growing prevalence of chronic diseases is a major driver for the digital therapeutics market. Conditions like diabetes, cardiovascular diseases, and obesity require continuous monitoring and management, often placing a strain on healthcare systems. Digital therapeutics offer a solution by providing personalized, scalable, and data-driven treatment plans that patient can access remotely. For example, mobile apps designed for diabetes management help patients track their glucose levels, adjust their diet, and maintain their medication schedule. As chronic diseases become more widespread due to aging populations and lifestyle factors, healthcare systems are turning to digital therapeutics as a cost-effective and efficient means to manage patient care. These tools not only help in monitoring the patient's condition but also support behavioral changes necessary for long-term disease management. By offering patients real-time feedback and continuous access to healthcare services, digital therapeutics are proving to be a valuable resource for managing chronic conditions.

Restraints in the Global Digital Therapeutics Market

One of the significant restraints in the digital therapeutics market is the complexity of the regulatory environment. Unlike traditional drugs and medical devices, digital therapeutics often fall into new or ambiguous categories, making it difficult for regulatory agencies like the FDA and EMA to establish clear approval guidelines. This regulatory uncertainty can delay product approvals and market entry, leading to longer development timelines and increased costs for companies. Moreover, the global nature of digital therapeutics presents additional challenges, as regulatory frameworks vary significantly from country to country. While some regions have established policies for digital health technologies, others are still developing regulatory mechanisms, creating hurdles for companies seeking to expand internationally. Concerns over patient data privacy, security, and compliance with healthcare regulations such as HIPAA also add to the complexity, making regulatory barriers one of the primary challenges in the market.

Market Trends of the Global Digital Therapeutics Market

The integration of artificial intelligence (AI) and machine learning (ML) technologies is a major trend in the digital therapeutics market. AI and ML enhance the capability of digital therapeutics by enabling the analysis of large volumes of patient data, thus facilitating more personalized treatment plans. These technologies can predict patient outcomes, optimize treatment regimens, and provide real-time interventions based on patient behavior and health metrics. For instance, AI-powered platforms for mental health can dynamically adjust therapy sessions based on patient responses, while AI in diabetes management tools can predict glucose level fluctuations and offer personalized recommendations. The ability to harness real-time data and predictive analytics improves the efficacy of digital therapeutics, making them more responsive to individual patient needs. As AI and ML technologies continue to advance, they are expected to further drive innovation and growth in the digital therapeutics sector, enhancing patient care and clinical outcomes.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Ecosystem of the Market
Top Investment Analysis
Key Success Factor
Degree of Competition
Technology Analysis
Value Chain Analysis
Pipeline Products Analysis
Case Study Analysis
Regulatory Landscape
Pricing Analysis
Patent Analysis

Digital Therapeutics Market by Offering

Market Overview
Software/Platforms
Programs
Virtual Reality/Games

Digital Therapeutics Market by Application

Market Overview
Treatment/Care-Related Applications
- Diabetes
- Central Nervous System (CNS) Disorders
- Mental Health Disorders
- Other CNS Disorders
- Smoking Cessation
- Chronic Respiratory Diseases
- Musculoskeletal Disorders
- Cardiovascular Diseases
- Medication Adherence
- Gastrointestinal Disorders
- Rehabilitation & Patient Care
- Substance Use Disorders & Addiction Management
- Other Treatment/Care-Related Applications
Preventive Applications
- Prediabetes
- Obesity
- Nutrition
- Lifestyle Management
- Other Preventive Applications

Digital Therapeutics Market by Revenue Model

Market Overview
Subscription-Based Model
One-Time Purchase/Annual Licensing Model
Outcome /Value-Based Model

Digital Therapeutics Market by Sales Channel

Market Overview
B2B Sales Channel
- Payers
- Employers
- Pharmaceutical Companies
- Providers
- Other Buyers
B2C Sales Channel
- Caregivers
- Patients

Digital Therapeutics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

ANSYS (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dassault Systemes (SIMULIA) (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PTC (Creo) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Digital Industries Software (Simcenter) (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Autodesk (Simulation) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OpenFOAM (Open-source) (N/A)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STAR-CCM+ (US/Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
COMSOL Multiphysics (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CD-adapco (STAR-CD, STAR-CCM+) (US/Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Altair (HyperWorks) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ESI Group (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MSC Software (MSC Adams, MSC Marc) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MathWorks (MATLAB/Simulink) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Flow3D (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluent (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CONVECTION (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cadence Design Systems (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synopsys (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Numerica (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pointwise (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments